Vivek Ramaswamy is an American businessman and entrepreneur who has a net worth of $500 million. Vivek Ramaswamy is best known for his company Axovant Sciences which is developing a new drug for Alzheimer’s. The company went public in June 2015 at the New York Stock Exchange and was the largest biotech IPO in the United States.
Vivek Ramaswamy founded Roivant Sciences which buys forgotten and abandoned drugs to develop them. He is the son of South Indian immigrants and was valedictorian of his high school. Vivek Ramaswamy studied at Harvard University and cofounded the company StudentBusinesses.com which he sold to the Ewing Marion Kauffman Foundation.
| Net Worth: | $500 Million |
| Date of Birth: | Aug 9, 1985 (36 years old) |
| Place of Birth: | Cincinnati, Ohio, U.S. |